Target Information

Target General Infomation
Target ID
T47215
Former ID
TTDR00566
Target Name
CCK receptor
Target Type
Discontinued
Disease Obesity [ICD9: 278; ICD10: E66]
Drugs and Mode of Action
Drug(s) A-68552 Drug Info Terminated Obesity [545004]
Modulator A-68552 Drug Info [550863]
Antagonist Loxiglumide Drug Info [538000]
References
Ref 545004Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001851)
Ref 538000Cholecystokinin receptor antagonist, loxiglumide, inhibits invasiveness of human pancreatic cancer cell lines. FEBS Lett. 1996 Apr 1;383(3):241-4.
Ref 550863CN patent application no. 102481276, Chemosensory receptor ligand-based therapies.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.